** RBC upgrades Franco-Italian eyewear maker EssilorLuxottica
ESLX.PA to "outperform" from "sector perform" citing strong
fundamentals and significant growth opportunities in the
ophthalmology market
** RBC estimates the total addressable market (TAM) for
ophthalmology to be valued at $36 billion, excluding the
pharmaceutical sector, with expected growth of 3-5% annually
** It says Essilor will primarily expand in subcategories
like contact lenses, surgery, and diagnostics
** "One percentage point of market share gained in this new
segment would offer $210m (or 0.8%) revenue uplift on our
estimates," RBC says
** It notes an opportunity for Essilor is the potential
acquisition of contact lens maker Bausch + Lomb BLCO.TO , which
is officially up for sale as of December
(Reporting by Alberto Chiumento)